Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 264

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

A Systematic Review of the Quality of Liver Biopsy Specimens

Cholongitas, Evangelos, Senzolo, Marco, Standish, Richard, Marelli, Laura, Quaglia, Alberto, Patch, David, Dhillon, Amar P., Burroughs, Andrew Kenneth·2006·American Journal of Clinical Pathology

Abstract

Characteristics for an optimal liver biopsy specimen were recently defined as 20 to 25 mm long and/or containing more than 11 complete portal tracts (CPTs). A systematic review of percutaneous liver biopsy (PLB) and transjugular liver biopsy (TJLB) series yielded only 32 PLB studies in which these characteristics were evaluated: mean +/- SD length, 17.7 +/- 5.8 mm and number of CPTs, 7.5 +/- 3.4; and 15 TJLB studies: mean +/- SD length, 13.5 +/- 4.5 mm and number of CPTs, 6.8 +/- 2.3. Studies of sampling heterogeneity and intraobserver and interobserver variability also used inadequate specimens by present standards. Only 11 (5.3%) of 207 therapeutic studies for chronic hepatitis B and C documented length and/or number of CPTs. Of the current 12 studies evaluating noninvasive fibrosis tests, only 8 documented length or number of CPTs, and only 1 documented length and number of CPTs. New studies are needed based on adequate liver biopsy samples to provide reliable estimation of grading and staging in chronic liver disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1309/w3xc-nt4h-kfbn-2g0b

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 79 references

Research works printed but not linked: 45

  1. Burroughs AK, Dagher L. Liver biopsy. In: Classen M, Tytgat G, Lightdale C, eds. Gastrointestinal Endoscopy. New York, NY: Thieme New York; 2002:252-259.
  2. Lee SS. Indicators and predictors of response to anti-viral therapy in chronic hepatitis C. Aliment Pharmacol Ther. 2003;17:611-621.
  3. DiMichele DM, Mirani G, Wilfredo CP, et al. Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection. Haemophilia. 2003;9:613-618.
  4. Kardache M, Soyer P, Boudiaf M, et al. Transjugular liver biopsy with an automated device. Radiology. 1997;204:369-372.
  5. De Hoyos A, Loredo ML, Martinez-Rios MA, et al. Transjugular liver biopsy in 52 patients with an automated Trucut-type needle. Dig Dis Sci. 1999;44:177-180.
  6. Gorriz E, Reyes R, Lobrano MB, et al. Transjugular liver biopsy: a review of 77 biopsies using a spring-propelled cutting needle (biopsy gun). Cardiovasc Intervent Radiol. 1996;19:442-445.
  7. Little AF, Zajko AB, Orons PD. Transjugular liver biopsy: a prospective study in 43 patients with the Quick-Core biopsy needle. J Vasc Interv Radiol. 1996;7:127-131.
  8. Cholongitas E, Quaglia A, Samonakis D, et al. Transjugular liver biopsy: is it effective for accurate histological interpretation [abstract]? Gut. 2005;54:A26.
  9. Andriulli A, Annese V, Facciorusso D, et al. First do no harm: power, oppression, and violence of liver biopsy [letter]. Gastroenterology. 2003;125:272-273.
  10. Chalmers RJ, Kirby B, Smith A, et al. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis. Br J Dermatol. 2005;152:444-450.
  11. Demetris AJ, Ruppert K. Pathologist's perspective on liver needle biopsy size? J Hepatol. 2003;39:275-277.
  12. Koukoulis GK. Chronic hepatitis C: grading, staging, and searching for reliable predictors of outcome. Hum Pathol. 2001;32:899-903.
  13. Papatheodoridis GV, Hadziyannis SJ. Current management of chronic hepatitis B. Aliment Pharmacol Ther. 2004;19:25-37.
  14. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495-500.
  15. Kugelmas M. Liver biopsy. Am J Gastroenterol. 2004;99:1416-1417.
  16. Gunneson TJ, Menon KV, Wiesner RH, et al. Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant. Am J Gastroenterol. 2002;97:1472-1475.
  17. Mayoral W, Lewis JH. Percutaneous liver biopsy: what is the current approach? results of a questionnaire survey. Dig Dis Sci. 2001;46:118-127.
  18. Robles-Diaz G, Chavez M, Lopez M, et al. Critical analysis of 1263 percutaneous hepatic biopsies carried out over a 12-year period (1970-1981) in the Salvador Zubiran National Institute of Nutrition [in Spanish]. Rev Gastroenterol Mex. 1985;50:13-17.
  19. Farrell RJ, Smiddy PF, Pilkington RM, et al. Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. J Hepatol. 1999;30:580-587.
  20. Papini E, Pacella CM, Rossi Z, et al. A randomized trial of ultrasound-guided anterior subcostal liver biopsy versus the conventional Menghini technique. J Hepatol. 1991;13:291-297.
  21. Muir AJ, Trotter JF. A survey of current liver biopsy practice patterns. J Clin Gastroenterol. 2002;35:86-88.
  22. Stotland BR, Lichtenstein GR. Liver biopsy complications and routine ultrasound [editorial]. Am J Gastroenterol. 1996;91:1295-1296.
  23. Bull HJ, Gilmore IT, Bradley RD, et al. Experience with transjugular liver biopsy. Gut. 1983;24:1057-1060.
  24. Papatheodoridis GV, Patch D, Watkinson A, et al. Transjugular liver biopsy in the 1990s: a 2-year audit. Aliment Pharmacol Ther. 1999;13:603-608.
  25. Holund B, Poulsen H, Schlichting P. Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. Scand J Gastroenterol. 1980;15:329-335.
  26. Schlichting P, Holund B, Poulsen H. Liver biopsy in chronic aggressive hepatitis: diagnostic reproducibility in relation to size of specimen. Scand J Gastroenterol. 1983;18:27-32.
  27. Azzem S, Schiano T, Bodian C, et al. Importance of specimen size inaccurate needle liver biopsy evaluation of patients with chronic hepatitis C. Hepatology. 2002;36:345A.
  28. Hopper KD, Abendroth CS, Sturtz KW, et al. Blinded comparison of biopsy needles and automated devices in vitro, 1: biopsy of diffuse hepatic disease. AJR Am J Roentgenol. 1993;161:1293-1297.
  29. Goldner F. Comparison of the Menghini, Klatskin and Tru-Cut needles in diagnosing cirrhosis. J Clin Gastroenterol. 1979;1:229-231.
  30. Flamm S, Upton M, Parker R, et al. Histopathologic heterogeneity in chronic hepatitis C virus infection: are two liver biopsy specimens better than one? Hepatology. 1995;22:A15.
  31. Bateson MC, Hopwood D, Duguid HL, et al. A comparative trial of liver biopsy needles. J Clin Pathol. 1980;33:131-133.
  32. Gurakar A, Balkan M, Fagiuoli S, et al. Experience with percutaneous liver biopsies using two different needles: a 14 G Trucut needle or a 15 G needle gun. Hepatology. 1993;16:A911.
  33. Spirchez Z, Fayad E, Albu S, et al. Comparison of two needles, the Surecut (18G) versus the biopsy gun (18G) in percutaneous liver biopsy. Hepatology. 1999;30:A1279.
  34. Regan J, Mihalov M, Limjoko A, et al. Transjugular liver biopsy: evaluation and comparison with percutaneous biopsy. Hepatology. 1997;26:281A.
  35. Judmaier G, Prior C, Klimpfinger M, et al. Is percutaneous liver biopsy using the Trucut (Travenol) needle superior to Menghini puncture [in German]?. Z Gastroenterol. 1989;27:657-661.
  36. Steadman C, Teague C, Harper J, et al. Transjugular liver biopsy: an Australian experience. Aust N Z J Med. 1988;18:836-840.
  37. Payen JL, Izopet J, Galindo-Migeot V, et al, for the Le Groupe D'etude et De Traitement du Virus De L'hepatite C (GetVhc). Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Hepatology. 1998;28:1680-1686.
  38. Bjoro K, Bell H, Myrvang B, et al. Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection: a randomized multicentre study. Scand J Gastroenterol. 2002;37:344-349.
  39. Bjoro K, Bell H, Hellum KB, et al. Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study. Scand J Gastroenterol. 2002;37:226-232.
  40. Bonkovsky HL, Stefancyk D, McNeal K, et al. Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial. Dig Dis Sci. 2001;46:2051-2059.
  41. Casanovas-Taltavull T, Baliellas C, Benasco C, et al. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation. Am J Gastroenterol. 2001;96:1170-1177.
  42. Schiff ER, Dienstag JL, Karayalcin S, et al. Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders. J Hepatol. 2003;38:818-826.
  43. Honkoop P, de Man RA, Zondervan PE, et al. Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine. Liver. 1997;17:103-106.
  44. Persico M, Palmentieri B, Vecchione R, et al. Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy [letter]. Am J Gastroenterol. 2002;97:491-492.
  45. Rozario R, Ramakrishna B. Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems. J Hepatol. 2003;38:223-229.

Cited by

See all 264

Metadata

Authors
Cholongitas, E., Senzolo, M., Standish, R., Marelli, L., Quaglia, A., Patch, D., Dhillon, A. P., & Burroughs, A. K.
Venue
American Journal of Clinical Pathology
Published
2006-05-01
Volume
125
Issue
5
Pages
710-721
ISSN
0002-9173 (ISSN-L)
OpenAlex
W4234983425
Cited by
264
References
79
FWCI
1.80
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Systematic Review of the Quality of Liver Biopsy Specimens. https://app.cochat.ai/papers/10.1309/w3xc-nt4h-kfbn-2g0b
The paper
Cholongitas, E., Senzolo, M., Standish, R., Marelli, L., Quaglia, A., Patch, D., Dhillon, A. P., & Burroughs, A. K. (2006). A Systematic Review of the Quality of Liver Biopsy Specimens. American Journal of Clinical Pathology. https://doi.org/10.1309/w3xc-nt4h-kfbn-2g0b

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.